Agência para o Investimento e Comércio Externo de Portugal


"Why Australia for Clinical Trials" will feature experts highlighting Australia's world-leading research capabilities, streamlined regulatory system and efficient grants and incentives. This free online event is scheduled for Thursday 30 November from 08:00 to 09:00 WET.

The agenda for this event includes an introduction to the Australian market as a favourable ecosystem for European companies to conduct clinical trials, an overview of the regulatory approval process for clinical trials, and insights into the R&D Tax Incentive and setting up in Australia. A case study will be presented and participants will have the opportunity to participate in a Q&A session.


Speakers for this event include:


- Naila Mazzucco, Trade & Investment Commissioner Italy, Czech Republic and Israel - Austrade

- James Dietrich, Head of Business Development UK & Europe - Acclime

- Katherine Martin, Investment Consultant - Austrade

- Jeffery Wong, Senior Director Business Development - Nucleus Network

- Frédéric Lacombe, Partner & Co-Founder - ASCIL Biopharm


To attend, please register here.